Trials / Unknown
UnknownNCT04405817
Outcome of Patients Treated With ECLS
Outcome of Patients Treated With Extracorporeal Life Support
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 1 Year – 100 Years
- Healthy volunteers
- —
Summary
Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.
Conditions
- Cardiogenic Shock
- Cardiac Arrest
- Heart Failure
- Acute Respiratory Failure
- Acute Respiratory Distress Syndrome
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ECMO | ECMO for circulatory and/or respiratory support |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2020-05-28
- Last updated
- 2020-05-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04405817. Inclusion in this directory is not an endorsement.